- FOUNDED 2009
Overview
The Neuroendocrine Tumours Group is concerned with the management of neuroendocrine tumours (NETs). NETs are composed of neuroendocrine cells that produce and secrete regulatory hormones and are present throughout the nervous and endocrine systems. NETs can occur at many sites in the body, but they are most common in the digestive system. NETs are uncommon tumours that have many unusual features.
This group recognises the difficulty in providing quality multidisciplinary care for patients suffering from NETs. It aims to provide a platform for discussing NET-related issues and to advocate for the care of patients with NETs.
Group information
[Chair] Dr David Chan, Royal North Shore Hospital, NSW
Dr Gabby Cehic, The Queen Elizabeth Hospital, SA
Ms Erin Laing, Peter MacCallum Cancer Centre, VIC
A/Prof Michael Michael, Peter MacCallum Cancer Centre, VIC
Prof Tim Price, The Queen Elizabeth Hospital, SA
Ms Kate Wakelin, NeuroEndocrine Cancer Australia, VIC
A/Prof David Wyld, Royal Brisbane Hospital, QLD
Read the Neuroendocrine Tumour Group Terms of Reference
Read the AGM Minutes from 1 November 2023
Read the AGM Minutes from 22 November 2021
Read the AGM Minutes from 23 November 2020
What’s the latest
Group Chair
Group Chair
David Chan
Neuroendocrine Tumours Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 8 hours ago
Join COSA, the national multidisciplinary community for health care professionals working in cancer care. Get involved and make a difference in cancer care through collaboration, research, advocacy and education: https://t.co/KyH4eMpIOp https://t.co/GshP848w1h
Read More >COSAoncology yesterday
RT @ACSC_PeterMac: Calling all clinicians interested in survivorship care for #cancersurvivors with treatable but not curable cancers. Regi…
Read More >COSAoncology yesterday
COSA's March eNews is in members' inboxes now ... ... or available to COSA members at https://t.co/DCJYUXIxl3 https://t.co/FW6f8nIXMg
Read More >COSAoncology 2 days ago
COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes. More on member benefits here: https://t.co/4Fw9lbNDrf https://t.co/EGBDBenLQp
Read More >COSAoncology 4 days ago
It only takes a few minutes to join COSA – Plus, join before 30 April 2024 and not only get bonus months of membership, but also save on member rates before prices increase for 2024! Join now: https://t.co/KyH4eMpIOp https://t.co/KuSX6hoRdv
Read More >COSAoncology 7 days ago
Make the most of your COSA membership savings! A discount applies if you’re a member of an Affiliated or Associated organisation. Plus - join before 30 April 2024 to get a saving on member rates before they increase for 2024. https://t.co/szOpiPmIr7 https://t.co/9bcc678y2C
Read More >COSAoncology 8 days ago
2023 was quite a year! COSA members will find the COSA Annual Report 2023 in their inboxes; everyone else can find it at https://t.co/a88OK0m92Z Contains reports from 36 COSA Groups and Affiliate Organisations, as well as overviews from the President, CEO and 2023 ASM Convenor. https://t.co/C1wQQLJQT7
Read More >COSAoncology 9 days ago
RT @LaceyJudith: National Symposium, few places left register now! @COSAoncology @COSA_Surviv @ABigaranAEP @davemiz_EP @DrNicolasHart @drc…
Read More >COSAoncology 10 days ago
RT @M_Jefford: Our correspondence, #OpenAccess in @JCO_ASCO today 🚨 shared care for #cancersurvivors is preferred by pts, cheaper for the h…
Read More >COSAoncology 10 days ago
RT @cancer_K2A: Another big day of great presentations at #WICC2024 If you’re interested in learning how #survonc & supportive care can im…
Read More >